From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics.

  title={From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics.},
  author={E. Want and A. Nordstr{\"o}m and H. Morita and G. Siuzdak},
  journal={Journal of proteome research},
  volume={6 2},
  • E. Want, A. Nordström, +1 author G. Siuzdak
  • Published 2007
  • Chemistry, Medicine
  • Journal of proteome research
  • Mass spectrometry (MS) is an established technology in drug metabolite analysis and is now expanding into endogenous metabolite research. Its utility derives from its wide dynamic range, reproducible quantitative analysis, and the ability to analyze biofluids with extreme molecular complexity. The aims of developing mass spectrometry for metabolomics range from understanding basic biochemistry to biomarker discovery and the structural characterization of physiologically important metabolites… CONTINUE READING
    227 Citations

    Figures, Tables, and Topics from this paper

    Targeted metabolomics for biomarker discovery.
    • 206
    Mass spectrometry: from proteomics to metabolomics and lipidomics.
    • W. Griffiths, Yuqin Wang
    • Chemistry, Medicine
    • Chemical Society reviews
    • 2009
    • 217
    • PDF
    Utility of separation science in metabolomic studies.
    • 57
    Analytical strategies for LC-MS-based targeted metabolomics.
    • 392
    • PDF
    Metabolome analysis by capillary electrophoresis-mass spectrometry.
    • 260
    LC-MS-Based Metabolomics in Drug Metabolism
    • 186
    Gas chromatography/mass spectrometry in metabolic profiling of biological fluids.
    • 251
    Promises and pitfalls of untargeted metabolomics
    • 33
    Global metabolic profiling procedures for urine using UPLC–MS
    • 573
    • PDF


    Nontargeted metabolome analysis by use of Fourier Transform Ion Cyclotron Mass Spectrometry.
    • 368
    GMD@CSB.DB: the Golm Metabolome Database
    • 1,017
    • PDF
    UPLC/MS(E); a new approach for generating molecular fragment information for biomarker structure elucidation.
    • 393